This is a genuinely contested question among experts, and I don't think a search would settle it—it's fundamentally a debate about values, risk tolerance, and competing predictions about the future, not a factual matter with a clear answer. But I can lay out the actual substance of the disagreement.
The case for pausing or restricting AI development:
•Existential/catastrophic risk concerns. Some researchers worry that sufficiently advanced AI systems could be difficult to control, could be misused catastrophically (bioweapons design, cyberattacks, disinformation at scale), or could pursue goals misaligned with human welfare. If you take these risks seriously and think alignment/safety research is lagging behind capability gains, slowing down looks prudent.
•Concentration of power. Rapid, unregulated development could hand enormous economic and political power to a small number of companies or states.
•Labor and social disruption. Fast deployment without adaptation time could cause severe economic dislocation.
•Precedent from other technologies. We regulate nuclear technology, gene editing, and pharmaceuticals before widespread deployment; some argue AI deserves similar caution given its potential impact.
The case against pausing (or for continuing with lighter-touch governance):
•Coordination problems. A pause in one country or by cooperating labs doesn't stop development elsewhere—it may just shift leadership to less safety-conscious actors, including authoritarian states.
•Opportunity cost. AI has plausible enormous upside: drug discovery, scientific research acceleration, economic productivity, education. Delay has real costs, especially in health and poverty reduction.
•Feasibility and enforcement. It's unclear how a "pause" would actually be verified or enforced technically—compute governance, model weight tracking, and international verification are all immature.
•Uncertainty about risk magnitude. Many researchers think near-term harms (bias, misinformation, job displacement, misuse) are more tractable and pressing than speculative existential risks, and that resources are better spent on targeted regulation than a blanket pause.
•Innovation dynamics. Historically, heavy-handed restriction can entrench incumbents and stifle beneficial innovation more than it prevents misuse.
A middle-ground view held by many policymakers and researchers:
Rather than a full pause, favor targeted interventions—transparency requirements, mandatory safety testing before deployment of frontier models, liability rules, export controls on advanced chips, international coordination bodies (analogous to nuclear nonproliferation regimes), and continued investment in interpretability and alignment research. This tries to capture AI's benefits while reducing tail risks and enabling course correction as capabilities evolve.
My honest take: I don't have a settled position I'd want to push on you, since reasonable, well-informed people land in very different places depending on how much weight they give to speculative catastrophic risks versus concrete near-term harms and opportunity costs, and how much they trust top-down restriction versus adaptive, iterative governance. If you want, I can go deeper into any specific angle—technical alignment risk, economic effects, specific regulatory proposals (like the EU AI Act or US executive actions), or the "pause letter" debate from 2023—and I can search for current developments if you want the latest state of play.